期刊文献+

不同作用靶点的bFGF反义脱氧寡核苷酸对胶质瘤SWO-38细胞效应的观察 被引量:1

Inhibitory effect of different target-side antisense oligonucleotides on bFGF expression in SWO-38 cells
下载PDF
导出
摘要 目的 :比较 3条针对不同位点的碱性成纤维细胞生长因子 (bFGF)反义脱氧寡核苷酸抑制神经胶质瘤SWO - 38细胞bFGF表达的效应。方法 :用脂质体介导bFGF反义脱氧寡核苷酸的转染入SWO - 38细胞 ,MTT及流式细胞术检测细胞增殖及凋亡的改变 ,Western -blot的方法检测bFGF蛋白水平的改变。结果 :3条脱氧寡核苷酸链的细胞增殖抑制率分别为 4 9% ,33% ,5 1% ,促进细胞凋亡率分别为 35 %、2 7%、18% ,对bFGF蛋白的表达降低分别为 6 3%、4 2 %、11%。结论 :对细胞增殖活力、凋亡率、bFGF蛋白水平均有明显效应的脱氧寡核苷酸序列才是理想的反义物质。 AIM: Three different antisense oligonucleotides complementary to basic fibroblast growth factor (bFGF) mRNA were compared in inhibitory effect on gene targeted expression. METHODS: After transfecting bFGF antisense oligonucleotides (asODN) into SWO-38 cells by lipofectin,the proliferation of cells was identified by MTT method, apoptosis was examined by flow cytometric cell cycle analysis and the expression levers of bFGF were detected by Western-blotting. RESULTS: There were 49%,33%,51% inhibition of cell growth and 35%, 27%, 18% cell apoptosis after asODN1, asODN2 and asODN3 treatment.In addition,the decrease in bFGF protein was 63%, 42%, 11%, respectively. CONCLUSION: The data suggeste that asODN1 is a potent target to bFGF mRNA, which inhibits cell growth and induces apoptosis in SWO-38 cells.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2003年第6期806-809,共4页 Chinese Journal of Pathophysiology
基金 广东省科技厅研究团队项目课题 (0 15 0 12 ) 广州市科技局科研重点立项课题 (2 0 0 1-E - 0 1- 2 ) 国家科技部重大基础研究前期研究专项 (2 0 0 2ccc0 4 0 0 ) 暨南大学医学院科研基金资助项目 (2 0 0 30 11)
关键词 成纤维细胞生长因子2 寡核苷酸类 反义 神经胶质瘤 Fibroblast growth factor 2 Oligonucleotides,antisense Glioma
  • 相关文献

参考文献10

  • 1秦艳芳,向军俭,杨红宇.碱性成纤维细胞生长因子与肿瘤[J].国外医学(肿瘤学分册),2001,28(4):256-259. 被引量:28
  • 2朱大明,宋照雷,孙奋勇,杨媛,段锐,林剑,洪岸.碱性成纤维细胞生长因子对β-淀粉样蛋白诱导PC12细胞凋亡的抑制作用[J].中国病理生理杂志,2002,18(4):374-377. 被引量:1
  • 3Nugent MA,Lo2zo RV. Fibroblast growth factor- 2[J]. Int J Biochem Cell Biol, 2000,32(2) : 115 - 120.
  • 4Okada- Ban M, Thiery J-P, Jouanneau J. Fibroblast growth factor- 2[J]. Int J Biochem,2000,32(Pt2) :263 - 267.
  • 5Delrieu I. The high molecular weight isoforms of basic fibroblast growth factor (FGF - 2): an insight into an intracrine mechanism[J] .FEBS Lett, 2000,468 (1):6- 10.
  • 6Temsamani J, Guinot P. Antisense oligonucleotides: a new therapeutic approach[J]. Biotechnol Appl Biochem, 1997,26(3):65 - 71.
  • 7Smith L, Andersen KB, Hovgaard L, et al. Rational selection of antisense oligonucleotide sequences[J]. Eur J Pharmaceut Sci,2002,11(3):191- 198.
  • 8Agrawal S. Antisense oligonucleotides: towards clinical trails[J]. Trends Biotech, 1996,14(10) :376 - 387.
  • 9Summerton J. Morpholino antisense oligomers: the ease for an RNase H - independent structural type [ J ]. Biochim Biophys Acta, 1999, 1489(1): 141-158.
  • 10Myoken Y, Myoken Y, Okamoto T, et al. Expression of fibroblast growth factor - 1, FGF - 2 and receptor - 1 in a humman salivary- gland adenocarcinoma cell line: evidence of autocrine growth[J] .Int J Cancer, 1996, 65 (5):650-657.

二级参考文献3

共引文献27

同被引文献4

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部